BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28327554)

  • 21. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
    Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta.
    Nadra K; Anghel SI; Joye E; Tan NS; Basu-Modak S; Trono D; Wahli W; Desvergne B
    Mol Cell Biol; 2006 Apr; 26(8):3266-81. PubMed ID: 16581799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARβ/δ activation protects against corticosterone-induced ER stress in astrocytes by inhibiting the CpG hypermethylation of microRNA-181a.
    Ji J; Zeng XN; Cao LL; Zhang L; Zhao Z; Yang DD; Sun XL
    Neuropharmacology; 2017 Feb; 113(Pt A):396-406. PubMed ID: 27789312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDGFR-β modulates vascular smooth muscle cell phenotype via IRF-9/SIRT-1/NF-κB pathway in subarachnoid hemorrhage rats.
    Wan W; Ding Y; Xie Z; Li Q; Yan F; Budbazar E; Pearce WJ; Hartman R; Obenaus A; Zhang JH; Jiang Y; Tang J
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1369-1380. PubMed ID: 29480757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells.
    Rodríguez AI; Csányi G; Ranayhossaini DJ; Feck DM; Blose KJ; Assatourian L; Vorp DA; Pagano PJ
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):430-8. PubMed ID: 25550204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-Activated Peroxisome Proliferator-Activated Receptor δ Attenuates Vascular Oxidative Stress by Inhibiting Thrombospondin-1 Expression.
    Ahn MY; Ham SA; Yoo T; Lee WJ; Hwang JS; Paek KS; Lim DS; Han SG; Lee CH; Seo HG
    J Vasc Res; 2018; 55(2):75-86. PubMed ID: 29408825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
    Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
    Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
    Zhang H; Pi R; Li R; Wang P; Tang F; Zhou S; Gao J; Jiang J; Chen S; Liu P
    Arch Biochem Biophys; 2007 Apr; 460(1):25-32. PubMed ID: 17346664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats.
    Larsen CC; Povlsen GK; Rasmussen MN; Edvinsson L
    J Neurosurg; 2011 Apr; 114(4):1143-53. PubMed ID: 20597604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
    Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
    Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.
    Li J; Xu S; Liu Y; Yan Z; Zhang F; Lv Q; Tong N
    Lipids; 2019 Oct; 54(10):603-616. PubMed ID: 31364177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression.
    Wagner KD; Du S; Martin L; Leccia N; Michiels JF; Wagner N
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis.
    Luz-Crawford P; Ipseiz N; Espinosa-Carrasco G; Caicedo A; Tejedor G; Toupet K; Loriau J; Scholtysek C; Stoll C; Khoury M; Noël D; Jorgensen C; Krönke G; Djouad F
    Ann Rheum Dis; 2016 Dec; 75(12):2166-2174. PubMed ID: 26964143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nutrient sensing pathways FoxO1/3 and mTOR in the heart are coordinately regulated by central leptin through PPARβ/δ. Implications in cardiac remodeling.
    Rubio B; Mora C; Pintado C; Mazuecos L; Fernández A; López V; Andrés A; Gallardo N
    Metabolism; 2021 Feb; 115():154453. PubMed ID: 33249043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.
    He P; Borland MG; Zhu B; Sharma AK; Amin S; El-Bayoumy K; Gonzalez FJ; Peters JM
    Toxicology; 2008 Dec; 254(1-2):112-7. PubMed ID: 18950674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.
    Pedchenko TV; Gonzalez AL; Wang D; DuBois RN; Massion PP
    Am J Respir Cell Mol Biol; 2008 Dec; 39(6):689-96. PubMed ID: 18566335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.